In deciding about HRT, the following points should be taken into account.
- HRT is effective in relieving hot flushes and night sweats, vaginal dryness and urinary symptoms.
- It is particularly helpful to women who have had a premature menopause (either natural or medically induced). They are likely to benefit most from HRT both because they tend to suffer more extreme symptoms of menopause and are at increased risk of osteoporosis and diseases of the heart and blood vessels, and because in many cases they no longer have a uterus and so the hormone therapy is simpler.
- Oestrogen used on its own seems to confer a worthwhile degree of protection against heart and blood vessel disease. This benefit is heightened for women who have had a hysterectomy and in whom there is no added risk of endometrial cancer.
- The decision about which HRT preparation is suitable for the larger number of women who have not had a hysterectomy depends on the balance between several potential benefits and hazards. On both scores, there are gaps in information that research will start to fill during the remainder of this decade.
-In deciding whether to undertake HRT for prolonged periods in the absence of worrisome symptoms, women should take account of both the anticipated benefits and the possible risks. On the benefit side, oestrogen use postpones bone thinning and reduces the likelihood of heart disease. When it is combined with a progestogen, there are still significant benefits for bones, but progestogen appears to negate some of the protective effect that oestrogen has on the cardiovascular system.
On the risk side, the biggest concerns lie with cancers of the breast and endometrium. Breast cancer is the most common cancer of the reproductive organs and the one most feared by women, so consideration of the link between oestrogen and breast cancer is tremendously important in helping women to decide about HRT. Statistical studies indicate that the number of women whose lives will be saved by HRT, through a reduction in serious bone breaks and heart attacks, is much greater than the number who will die through cancer. However if, for a particular woman, the avoidance of an increased cancer risk is more important than the numerically greater benefit in terms of osteoporosis or cardiovascular disease, this is clearly the basis on which her treatment should be decided.
For many women, drawbacks to combined oestrogen and progestogen include withdrawal bleeding, breakthrough bleeding and PMS-like side effects.
For women who use oestrogen on its own and who still have a uterus, an important consideration is the need for regular and extended monitoring of their gynaecological health.
*136\38\8*
Tags: Hormonal